Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (441-450 of 843) with videos related to

Pageof 85
Sort By:
AIDS (London, England)|August 12, 2011
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infectionNicole L Yates, Judith T Lucas, Tracy L Nolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2011
Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controlsLaurent Verkoczy, Yao Chen, Hilary Bouton-Verville, et al.
Journal of Virology|July 8, 2011
epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individualsHaili Tang, James E Robinson, S Gnanakaran, et al.
Virology|October 26, 2005
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolatesBarton F Haynes, Benjiang Ma, David C Montefiori, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
Journal of Virology|December 10, 1999
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strainsH X Liao, B Etemad-Moghadam, D C Montefiori, et al.
Journal of Virology|November 26, 2010
Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigensS Moses Dennison, Kara Anasti, Richard M Scearce, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1980
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humansB F Haynes, D L Mann, M E Hemler, et al.
Journal of Virology|January 12, 2023
Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and YieldDaniel Wrapp, Zekun Mu, Bhishem Thakur, et al.
Journal of Virology|December 26, 2008
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccinationWing-Pui Kong, Lan Wu, Timothy C Wallstrom, et al.
Pageof 85

Showing results (441-450 of 843) with videos related to

Sort By:
Pageof 85
AIDS (London, England)|August 12, 2011
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infectionNicole L Yates, Judith T Lucas, Tracy L Nolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2011
Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controlsLaurent Verkoczy, Yao Chen, Hilary Bouton-Verville, et al.
Journal of Virology|July 8, 2011
epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individualsHaili Tang, James E Robinson, S Gnanakaran, et al.
Virology|October 26, 2005
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolatesBarton F Haynes, Benjiang Ma, David C Montefiori, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
Journal of Virology|December 10, 1999
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strainsH X Liao, B Etemad-Moghadam, D C Montefiori, et al.
Journal of Virology|November 26, 2010
Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigensS Moses Dennison, Kara Anasti, Richard M Scearce, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1980
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humansB F Haynes, D L Mann, M E Hemler, et al.
Journal of Virology|January 12, 2023
Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and YieldDaniel Wrapp, Zekun Mu, Bhishem Thakur, et al.
Journal of Virology|December 26, 2008
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccinationWing-Pui Kong, Lan Wu, Timothy C Wallstrom, et al.
Pageof 85